132 related articles for article (PubMed ID: 37230631)
1. In vitro and in vivo assessment of structural integrity for HPCD complex@Liposome nanocomposites from ocular surface to the posterior segment of the eye.
Lu J; Zhu X; Zhang M; Jiang X; Guo W; Jiang F; Cao F
Carbohydr Polym; 2023 Sep; 315():120960. PubMed ID: 37230631
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Nanocomposites Based on Liposomes and Layered Double Hydroxides Conjugated with Glycylsarcosine for Efficient Topical Drug Delivery to the Posterior Segment of the Eye.
Gu Y; Xu C; Wang Y; Zhou X; Fang L; Cao F
Mol Pharm; 2019 Jul; 16(7):2845-2857. PubMed ID: 31244219
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional carboxymethyl chitosan derivatives-layered double hydroxide hybrid nanocomposites for efficient drug delivery to the posterior segment of the eye.
Wang Y; Zhou L; Fang L; Cao F
Acta Biomater; 2020 Mar; 104():104-114. PubMed ID: 31931169
[TBL] [Abstract][Full Text] [Related]
4. Rational design of mixed nanomicelle eye drops with structural integrity investigation.
Sun L; Zhang M; Shi Y; Fang L; Cao F
Acta Biomater; 2022 Mar; 141():164-177. PubMed ID: 35032720
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional nanocomposite eye drops of cyclodextrin complex@layered double hydroxides for relay drug delivery to the posterior segment of the eye.
Xu C; Lu J; Zhou L; Liang J; Fang L; Cao F
Carbohydr Polym; 2021 May; 260():117800. PubMed ID: 33712148
[TBL] [Abstract][Full Text] [Related]
6. Effect of 2-hydroxypropyl-beta-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate.
Usayapant A; Karara AH; Narurkar MM
Pharm Res; 1991 Dec; 8(12):1495-9. PubMed ID: 1808612
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin-Coordinated Liposome-in-Gel for Transcutaneous Quercetin Delivery for Psoriasis Treatment.
Zhang Y; Gong S; Liu L; Shen H; Liu E; Pan L; Gao N; Chen R; Huang Y
ACS Appl Mater Interfaces; 2023 Aug; 15(34):40228-40240. PubMed ID: 37584330
[TBL] [Abstract][Full Text] [Related]
8. 2-Hydroxypropyl-β-cyclodextrin reduces retinal cholesterol in wild-type and Cyp27a1
El-Darzi N; Mast N; Petrov AM; Pikuleva IA
Br J Pharmacol; 2021 Aug; 178(16):3220-3234. PubMed ID: 32698250
[TBL] [Abstract][Full Text] [Related]
9. Interaction with Modified Cyclodextrin as a Way to Increase the Antimalarial Activity of Primaquine.
Torres LH; de Carvalho LB; de Fátima Abreu Venceslau A; Jaime C; de Matos Alves Pinto L
Curr Drug Discov Technol; 2020; 17(5):670-681. PubMed ID: 31438828
[TBL] [Abstract][Full Text] [Related]
10. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
Loftsson T; Sigurdsson HH; Konrádsdóttir F; Gísladóttir S; Jansook P; Stefánsson E
Pharmazie; 2008 Mar; 63(3):171-9. PubMed ID: 18444504
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.
McCormack B; Gregoriadis G
Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
[TBL] [Abstract][Full Text] [Related]
13. The Drug Excipient Cyclodextrin Interacts With d-Luciferin and Interferes With Bioluminescence Imaging.
Kumar JS; Miller Jenkins LM; Gottesman MM; Hall MD
Mol Imaging; 2016; 15():. PubMed ID: 27030398
[TBL] [Abstract][Full Text] [Related]
14. Thiolated Hydroxypropyl-β-cyclodextrin: A Potential Multifunctional Excipient for Ocular Drug Delivery.
Grassiri B; Knoll P; Fabiano A; Piras AM; Zambito Y; Bernkop-Schnürch A
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269753
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery System.
Ferrati S; Nicolov E; Bansal S; Hosali S; Landis M; Grattoni A
Curr Drug Targets; 2015; 16(14):1645-9. PubMed ID: 25706254
[TBL] [Abstract][Full Text] [Related]
16. Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs.
Brewster ME; Hora MS; Simpkins JW; Bodor N
Pharm Res; 1991 Jun; 8(6):792-5. PubMed ID: 2062811
[TBL] [Abstract][Full Text] [Related]
17. Influence of hydroxypropyl-beta-cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone.
Felton LA; Wiley CJ; Godwin DA
Drug Dev Ind Pharm; 2002 Oct; 28(9):1117-24. PubMed ID: 12455470
[TBL] [Abstract][Full Text] [Related]
18. Reduction of enhanced rabbit intraocular pressure by instillation of pyroglutamic acid eye drops.
Ito Y; Nagai N; Okamoto N; Shimomura Y; Nakanishi K; Tanaka R
Biol Pharm Bull; 2013; 36(6):1017-23. PubMed ID: 23727922
[TBL] [Abstract][Full Text] [Related]
19. Investigation into the mechanism by which cyclodextrins influence transdermal drug delivery.
Kear CL; Yang J; Godwin DA; Felton LA
Drug Dev Ind Pharm; 2008 Jul; 34(7):692-7. PubMed ID: 18608463
[TBL] [Abstract][Full Text] [Related]
20. Supramolecular nanogels based on gelatin-cyclodextrin-stabilized silver nanocomposites with antibacterial and anticancer properties.
Mohandoss S; Palanisamy S; You S; Shim JJ; Lee YR
J Biomater Sci Polym Ed; 2022 Apr; 33(6):689-704. PubMed ID: 35025724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
